Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT00662038 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00662038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00662038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Lead sponsor
Genentech, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
February 29, 2016
Enrollment
1,058 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis